GKIM
GMAB icon

GW&K Investment Management’s Genmab GMAB Stock Holding History

GW&K Investment Management’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4K Hold
156
– – ﹤0.01% 1017
2026
Q1 		$4K Buy
156
+16
+11% +$479 ﹤0.01% 955
2025
Q4 		$4K Hold
140
– – ﹤0.01% 937
2025
Q3 		$4K Hold
140
– – ﹤0.01% 933
2025
Q2 		$3K Hold
140
– – ﹤0.01% 934
2025
Q1 		$3K Hold
140
– – ﹤0.01% 942
2024
Q4 		$3K Buy
140
+42
+43% +$923 ﹤0.01% 901
2024
Q3 		$2K Buy
98
+4
+4% +$107 ﹤0.01% 909
2024
Q2 		$2K Sell
94
-15
-14% -$425 ﹤0.01% 878
2024
Q1 		$3K Buy
109
+46
+73% +$1.35K ﹤0.01% 831
2023
Q4 		$2K Hold
63
– – ﹤0.01% 863
2023
Q3 		$2K Hold
63
– – ﹤0.01% 845
2023
Q2 		$2K Buy
+63
New +$2.51K ﹤0.01% 839

Other funds holding GMAB

PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

GW&K Investment Management's GMAB Position: Q2 2026 in Review

GW&K Investment Management held its Genmab (GMAB) position steady in Q2 2026 at 156 shares worth $4K. The position accounts for ﹤0.01% of the portfolio, ranked #1017.

GW&K Investment Management first reported a position in GMAB in Q2 2023 and has held it in 13 quarters since. 290 funds tracked by Wall St. Rank hold GMAB as of Q2 2026.

  • GW&K Investment Management held 156 shares of Genmab worth $4K as of Q2 2026.
  • GW&K Investment Management left its Genmab share count unchanged in Q2 2026.
  • Genmab made up ﹤0.01% of GW&K Investment Management's portfolio in Q2 2026, its #1017 holding.
  • GW&K Investment Management first reported a position in Genmab in Q2 2023 and has held it in 13 quarters since.
  • 290 funds tracked by Wall St. Rank held Genmab as of Q2 2026.

Based on GW&K Investment Management's 13F filing for Q2 2026, filed 12 Aug 2026.